These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11098881)

  • 1. Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders.
    King BH
    J Autism Dev Disord; 2000 Oct; 30(5):439-45. PubMed ID: 11098881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: considerations on the characterization and treatment of self-injurious behavior.
    Ernst M
    J Autism Dev Disord; 2000 Oct; 30(5):447-50. PubMed ID: 11098882
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management in children and adolescents with pervasive developmental disorder.
    Sung M; Fung DS; Cai Y; Ooi YP
    Aust N Z J Psychiatry; 2010 May; 44(5):410-28. PubMed ID: 20047454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
    Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ
    J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatments in patients with pervasive developmental disorders: A review].
    Béhérec L; Quilici G; Rosier A; Gerardin P; Campion D; Guillin O
    Encephale; 2014 Apr; 40(2):188-96. PubMed ID: 24369879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral approaches to managing severe problem behaviors in children with autism spectrum and related developmental disorders: a descriptive analysis.
    Doehring P; Reichow B; Palka T; Phillips C; Hagopian L
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):25-40. PubMed ID: 24231165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral treatment of self-starvation and severe self-injury in a patient with borderline personality disorder.
    Bloxham G; Long CG; Alderman N; Hollin CR
    J Behav Ther Exp Psychiatry; 1993 Sep; 24(3):261-7. PubMed ID: 8188851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
    Parikh MS; Kolevzon A; Hollander E
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of autism spectrum disorders.
    Benvenuto A; Battan B; Porfirio MC; Curatolo P
    Brain Dev; 2013 Feb; 35(2):119-27. PubMed ID: 22541665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.
    Aman MG
    Semin Pediatr Neurol; 2004 Sep; 11(3):225-8. PubMed ID: 15575418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder.
    Frazier TW; Youngstrom EA; Haycook T; Sinoff A; Dimitriou F; Knapp J; Sinclair L
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):167-77. PubMed ID: 20578929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacologic management of serious behavioral disturbance in ASD.
    Stigler KA
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral assessment and treatment of self-injurious behavior in autism.
    Minshawi NF
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):875-86, x. PubMed ID: 18775375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.